Astellas is already a proven player in the fields of Oncology, Transplantation, Urology and Anti-Infectives – a position we have achieved through a commitment to innovation.
With approximately 16% of our sales being invested into research, we are dedicated to building a strong presence in this most challenging of therapeutic areas, where a high level of unmet medical need exists.
We have a number of therapies under clinical development. Through these programmes, we aim to fulfil not just our potential, but our promise to change tomorrow for patients.
NPR17018Ukb – June 2018
Learn more about our therapy areas:
Well established therapies to prevent organ rejection after transplantation
Leading research to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections